-
1
-
-
0023929722
-
Prediction of risk of anterior myocardial infarction by lesion severity and measurement method of stenoses in the left anterior descending coronary distribution: A CASS Registry Study
-
Ellis S, Alderman E, Cain K, Fisher L, Sanders W, Bourassa M. Prediction of risk of anterior myocardial infarction by lesion severity and measurement method of stenoses in the left anterior descending coronary distribution: a CASS Registry Study. J Am Coll Cardiol. 1988;11(5):908-16.
-
(1988)
J Am Coll Cardiol
, vol.11
, Issue.5
, pp. 908-916
-
-
Ellis, S.1
Alderman, E.2
Cain, K.3
Fisher, L.4
Sanders, W.5
Bourassa, M.6
-
2
-
-
0035902456
-
Current concepts of the pathogenesis of the acute coronary syndromes
-
Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 2001;104(3):365-72.
-
(2001)
Circulation
, vol.104
, Issue.3
, pp. 365-372
-
-
Libby, P.1
-
3
-
-
77953952667
-
Concept of vulnerable/ unstable plaque
-
Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R. Concept of vulnerable/ unstable plaque. Arterioscler Thromb Vasc Biol. 2010;30(7):1282-92.
-
(2010)
Arterioscler Thromb Vasc Biol
, vol.30
, Issue.7
, pp. 1282-1292
-
-
Finn, A.V.1
Nakano, M.2
Narula, J.3
Kolodgie, F.D.4
Virmani, R.5
-
4
-
-
0032935707
-
Upregulation of cholesterol synthesis after acute myocardial infarction--is cholesterol a positive acute phase reactant?
-
Pfohl M, Schreiber I, Liebich HM, Haring HU, Hoffmeister HM. Upregulation of cholesterol synthesis after acute myocardial infarction--is cholesterol a positive acute phase reactant? Atherosclerosis. 1999;142(2):389-93.
-
(1999)
Atherosclerosis
, vol.142
, Issue.2
, pp. 389-393
-
-
Pfohl, M.1
Schreiber, I.2
Liebich, H.M.3
Haring, H.U.4
Hoffmeister, H.M.5
-
5
-
-
23944445364
-
Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol
-
Liao JK. Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol. Am J Cardiol. 2005; 96(5A):24F-33F.
-
(2005)
Am J Cardiol
, vol.96 A
, Issue.5
-
-
Liao, J.K.1
-
6
-
-
0036790614
-
Statin therapy in acute coronary syndromes: Mechanistic insight into clinical benefit
-
Sposito AC, Chapman MJ. Statin therapy in acute coronary syndromes: mechanistic insight into clinical benefit. Arterioscler Thromb Vasc Biol. 2002;22(10):1524-34.
-
(2002)
Arterioscler Thromb Vasc Biol
, vol.22
, Issue.10
, pp. 1524-1534
-
-
Sposito, A.C.1
Chapman, M.J.2
-
7
-
-
0037177167
-
Withdrawal of statins increases event rates in patients with acute coronary syndromes
-
Heeschen C, Hamm CW, Laufs U, Snapinn S, Bohm M, White HD. Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation. 2002;105(12):1446-52.
-
(2002)
Circulation
, vol.105
, Issue.12
, pp. 1446-1452
-
-
Heeschen, C.1
Hamm, C.W.2
Laufs, U.3
Snapinn, S.4
Bohm, M.5
White, H.D.6
-
8
-
-
2542422856
-
Association of statin therapy with outcomes of acute coronary syndromes: The GRACE study
-
Spencer FA, Allegrone J, Goldberg RJ, Gore JM, Fox KA, Granger CB, et al. Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study. Ann Intern Med. 2004;140(11):857-66.
-
(2004)
Ann Intern Med
, vol.140
, Issue.11
, pp. 857-866
-
-
Spencer, F.A.1
Allegrone, J.2
Goldberg, R.J.3
Gore, J.M.4
Fox, K.A.5
Granger, C.B.6
-
9
-
-
6944240055
-
Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction: National registry of myocardial infarction
-
Spencer FA, Fonarow GC, Frederick PD, Wright RS, Every N, Goldberg RJ, et al. Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction: national registry of myocardial infarction. Arch Intern Med. 2004;164(19):2162-8.
-
(2004)
Arch Intern Med
, vol.164
, Issue.19
, pp. 2162-2168
-
-
Spencer, F.A.1
Fonarow, G.C.2
Frederick, P.D.3
Wright, R.S.4
Every, N.5
Goldberg, R.J.6
-
10
-
-
23944497531
-
Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality
-
Fonarow GC, Wright RS, Spencer FA, Fredrick PD, Dong W, Every N, et al. Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality. Am J Cardiol. 2005;96(5):611-6.
-
(2005)
Am J Cardiol
, vol.96
, Issue.5
, pp. 611-616
-
-
Fonarow, G.C.1
Wright, R.S.2
Spencer, F.A.3
Fredrick, P.D.4
Dong, W.5
Every, N.6
-
11
-
-
41749111163
-
Intensive statin therapy in acute coronary syndromes
-
Liew T V, Ray KK. Intensive statin therapy in acute coronary syndromes. Curr Atheroscler Rep. 2008;10(2):158-63.
-
(2008)
Curr Atheroscler Rep
, vol.10
, Issue.2
, pp. 158-163
-
-
Liew, T.V.1
Ray, K.K.2
-
12
-
-
0035941512
-
Early statin treatment following acute myocardial infarction and 1-year survival
-
Stenestrand U, Wallentin L. Early statin treatment following acute myocardial infarction and 1-year survival. JAMA. 2001;285(4):430-6.
-
(2001)
JAMA
, vol.285
, Issue.4
, pp. 430-436
-
-
Stenestrand, U.1
Wallentin, L.2
-
13
-
-
0034954285
-
Pravastatin in acute ischaemic syndromes: Results of a randomised placebo-controlled trial
-
Den Hartog FR, Van Kalmthout PM, Van Loenhout TT, Schaafsma HJ, Rila H, Verheugt FW. Pravastatin in acute ischaemic syndromes: results of a randomised placebo-controlled trial. Int J Clin Pract. 2001;55(5):300-4.
-
(2001)
Int J Clin Pract
, vol.55
, Issue.5
, pp. 300-304
-
-
den Hartog, F.R.1
van Kalmthout, P.M.2
van Loenhout, T.T.3
Schaafsma, H.J.4
Rila, H.5
Verheugt, F.W.6
-
14
-
-
0030940746
-
Time course of serum lipids and apolipoproteins after acute myocardial infarction: Modification by pravastatin
-
Kesteloot H, Claeys G, Blanckaert N, Lesaffre E. Time course of serum lipids and apolipoproteins after acute myocardial infarction: modification by pravastatin. Acta Cardiol. 1997;52(2):107-16.
-
(1997)
Acta Cardiol
, vol.52
, Issue.2
, pp. 107-116
-
-
Kesteloot, H.1
Claeys, G.2
Blanckaert, N.3
Lesaffre, E.4
-
15
-
-
0033614802
-
Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes
-
The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial
-
Dupuis J, Tardif JC, Cernacek P, Theroux P. Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial. Circulation. 1999;99(25):3227-33.
-
(1999)
Circulation
, vol.99
, Issue.25
, pp. 3227-3233
-
-
Dupuis, J.1
Tardif, J.C.2
Cernacek, P.3
Theroux, P.4
-
16
-
-
0034672571
-
Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study)
-
Arntz HR, Agrawal R, Wunderlich W, Schnitzer L, Stern R, Fischer F, et al. Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study). Am J Cardiol. 2000;86(12):1293-8.
-
(2000)
Am J Cardiol
, vol.86
, Issue.12
, pp. 1293-1298
-
-
Arntz, H.R.1
Agrawal, R.2
Wunderlich, W.3
Schnitzer, L.4
Stern, R.5
Fischer, F.6
-
17
-
-
0036899472
-
Effect of fluvastatin on ischaemia following acute myocardial infarction: A randomized trial
-
Liem AH, van Boven AJ, Veeger NJ, Withagen AJ, Robles de Medina RM, Tijssen JG, et al. Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial. Eur Heart J. 2002;23(24):1931-7.
-
(2002)
Eur Heart J
, vol.23
, Issue.24
, pp. 1931-1937
-
-
Liem, A.H.1
van Boven, A.J.2
Veeger, N.J.3
Withagen, A.J.4
de Medina, R.M.R.5
Tijssen, J.G.6
-
18
-
-
17944396864
-
Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: The Pravastatin in Acute Coronary Treatment (PACT) trial
-
Thompson PL, Meredith I, Amerena J, Campbell TJ, Sloman JG, Harris PJ. Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: the Pravastatin in Acute Coronary Treatment (PACT) trial. Am Heart J. 2004;148(1):e2.
-
(2004)
Am Heart J
, vol.148
, Issue.1
-
-
Thompson, P.L.1
Meredith, I.2
Amerena, J.3
Campbell, T.J.4
Sloman, J.G.5
Harris, P.J.6
-
19
-
-
4544243333
-
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: Phase Z of the A to Z trial
-
de Lemos JA, Blazing MA, Wiviott SD, Lewis E F, Fox KA, White HD, et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. JAMA. 2004;292(11):1307-16.
-
(2004)
JAMA
, vol.292
, Issue.11
, pp. 1307-1316
-
-
de Lemos, J.A.1
Blazing, M.A.2
Wiviott, S.D.3
Lewis, E.F.4
Fox, K.A.5
White, H.D.6
-
20
-
-
0035804846
-
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: The MIRACL study: A randomized controlled trial
-
Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver M F, Waters D, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA. 2001;285(13):1711-8.
-
(2001)
JAMA
, vol.285
, Issue.13
, pp. 1711-1718
-
-
Schwartz, G.G.1
Olsson, A.G.2
Ezekowitz, M.D.3
Ganz, P.4
Oliver, M.F.5
Waters, D.6
-
21
-
-
11144355354
-
Intensive versus moderate lipid lowering with statins after acute coronary syndromes
-
Cannon C P, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350(15):1495-504.
-
(2004)
N Engl J Med
, vol.350
, Issue.15
, pp. 1495-1504
-
-
Cannon, C.P.1
Braunwald, E.2
McCabe, C.H.3
Rader, D.J.4
Rouleau, J.L.5
Belder, R.6
-
22
-
-
23944446113
-
Early time to benefit with intensive statin treatment: Could it be the pleiotropic effects?
-
Ray KK, Cannon C P. Early time to benefit with intensive statin treatment: could it be the pleiotropic effects? Am J Cardiol. 2005;96(5A):54F-60F.
-
(2005)
Am J Cardiol
, vol.96 A
, Issue.5
-
-
Ray, K.K.1
Cannon, C.P.2
-
23
-
-
27744603499
-
High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: The IDEAL study: A randomized controlled trial
-
Pedersen TR, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Holme I, et al. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. JAMA. 2005;294(19):2437-45.
-
(2005)
JAMA
, vol.294
, Issue.19
, pp. 2437-2445
-
-
Pedersen, T.R.1
Faergeman, O.2
Kastelein, J.J.3
Olsson, A.G.4
Tikkanen, M.J.5
Holme, I.6
-
24
-
-
18744373337
-
High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: Results from the MIRACL trial
-
Olsson AG, Schwartz GG, Szarek M, Sasiela WJ, Ezekowitz MD, Ganz P, et al. High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial. Eur Heart J. 2005;26(9):890-6.
-
(2005)
Eur Heart J
, vol.26
, Issue.9
, pp. 890-896
-
-
Olsson, A.G.1
Schwartz, G.G.2
Szarek, M.3
Sasiela, W.J.4
Ezekowitz, M.D.5
Ganz, P.6
-
25
-
-
50949102416
-
Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): Comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes
-
Cannon C P, Giugliano R P, Blazing MA, Harrington RA, Peterson JL, Sisk CM, et al. Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes. Am Heart J. 2008;156(5):826-32.
-
(2008)
Am Heart J
, vol.156
, Issue.5
, pp. 826-832
-
-
Cannon, C.P.1
Giugliano, R.P.2
Blazing, M.A.3
Harrington, R.A.4
Peterson, J.L.5
Sisk, C.M.6
-
26
-
-
77951622890
-
An update on the IMProved reduction of outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) design
-
Califf RM, Lokhnygina Y, Cannon C P, Stepanavage ME, McCabe CH, Musliner TA, et al. An update on the IMProved reduction of outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) design. Am Heart J. 2010;159(5):705-9.
-
(2010)
Am Heart J
, vol.159
, Issue.5
, pp. 705-709
-
-
Califf, R.M.1
Lokhnygina, Y.2
Cannon, C.P.3
Stepanavage, M.E.4
McCabe, C.H.5
Musliner, T.A.6
-
27
-
-
34547403141
-
Sociedade Brasileira de Cardiologia. IV Diretrizes brasileiras para dislipidemias e prevenção da aterosclerose
-
Sposito AC, Caramelli B, Fonseca FA, Bertolami MC, Afiune NA, Souza AD, et al./Sociedade Brasileira de Cardiologia. IV Diretrizes brasileiras para dislipidemias e prevenção da aterosclerose. Arq Bras Cardiol. 2007;88 (supl 1):2-19.
-
(2007)
Arq Bras Cardiol
, vol.88
, Issue.SUPPL. 1
, pp. 2-19
-
-
Sposito, A.C.1
Caramelli, B.2
Fonseca, F.A.3
Bertolami, M.C.4
Afiune, N.A.5
Souza, A.D.6
-
28
-
-
79955540734
-
Sociedade Brasileira de Cardiologia. Diretriz sobre tratamento do infarto agudo do miocárdio com supradesnível do segmento ST
-
Piegas LS, Timerman A, Feitosa G, Mattos LA, Nicolau JS, Rossi Neto JM, et al./Sociedade Brasileira de Cardiologia. Diretriz sobre tratamento do infarto agudo do miocárdio com supradesnível do segmento ST. Arq Bras Cardiol. 2009;93(6 supl.2):e179-e264.
-
(2009)
Arq Bras Cardiol
, vol.93
, Issue.6 SUPPL.2
-
-
Piegas, L.S.1
Timerman, A.2
Feitosa, G.3
Mattos, L.A.4
Nicolau, J.S.5
Rossi-Neto, J.M.6
-
29
-
-
77955679619
-
Redefining normal low-density lipoprotein cholesterol: A strategy to unseat coronary disease as the nation's leading killer
-
Forrester JS. Redefining normal low-density lipoprotein cholesterol: a strategy to unseat coronary disease as the nation's leading killer. J Am Coll Cardiol. 2010;56(8):630-6.
-
(2010)
J Am Coll Cardiol
, vol.56
, Issue.8
, pp. 630-636
-
-
Forrester, J.S.1
|